超声引导下经皮射频与微波消融治疗甲状腺乳头状癌颈部淋巴结转移:临床疗效与安全性的系统评价和荟萃分析
该系统评价纳入11项研究、233例患者、432个颈部淋巴结转移灶,评估射频消融(RFA)和微波消融(MWA)的疗效与安全性。汇总体积缩小率为95.24%,完全消失率63.1%,复发率1.6%,主要并发症3.0%,次要并发症25.6%。MWA的体积缩小率(97.18%)高于RFA(93.84%)(P < 0.001)。
要点
- 汇总体积缩小率95.24%(95%CI 91.97-98.51%),完全消失率63.1%,复发率1.6%。
- MWA的体积缩小率97.18%高于RFA的93.84%(P < 0.001)。
- 主要并发症发生率3.0%,次要并发症发生率25.6%。
核心结论
- RFA和MWA治疗PTC颈部淋巴结转移均有效且安全,但RFA的体积缩小率低于MWA,且VRR存在显著异质性。
研究设计与样本
- 系统评价和荟萃分析,检索Medline、EMBASE、Web of Science和Cochrane Library至2024年7月,最终纳入11篇文章、233例患者、432个颈部淋巴结转移灶,采用随机或固定效应模型评估汇总比例,使用Q统计量和I²分析异质性,使用MINORS量表评估研究质量。
诊断标准与关键数值
- 汇总体积缩小率为95.24%(95%CI 91.97-98.51%)。
- 完全消失率为63.1%,复发率为1.6%。
- 最大径变化为8.36 mm(95%CI 6.46-10.26 mm),体积变化为216.09 mm³,血清Tg变化为6.12 ng/ml。
- 主要并发症发生率为3.0%,次要并发症发生率为25.6%。
- 亚组分析显示MWA的体积缩小率(97.18%)高于RFA(93.84%)(P < 0.001)。
临床应用与阅片要点
- 作者认为RFA和MWA治疗PTC颈部淋巴结转移均有效且安全。
- 作者指出RFA的体积缩小率低于MWA,且VRR存在显著异质性。
局限性
- 直径、体积、VRR、Tg和次要并发症存在显著异质性。
- RFA的VRR低于MWA且VRR存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the efficacy and safety of radiofrequency ablation (RFA) and microwave ablation (MWA) for treating cervical lymph node metastasis (CLNM) from papillary thyroid carcinoma (PTC).
METHODS: Medline, EMBASE, Web of Science, and Cochrane Library were searched for studies on the efficacy and safety of thermal ablations for treating CLNM from PTC until July 2024. Among 544 papers, 11 articles were reviewed involving 233 patients and 432 CLNM cases. Random- or fixed-effects models assessed pooled proportions of volume reduction rate (VRR), complete disappearance, recurrence, major and minor or other complications. Similarly, pooled estimates of changes in the largest diameter, volume, and serum thyroglobulin (Tg) were evaluated post-ablation. Subgroup analysis by treatment modality was performed. Study heterogeneity was analyzed using Q statistics and inconsistency index (I2). The quality of the studies was assessed using the MINORS scale.
RESULTS: Eleven studies with 233 patients and 432 CLNM were analyzed. The pooled VRR was 95.24% [95% Confidence Interval (CI): 91.97- 98.51%], complete disappearance was 63.1%, and recurrence was 1.6%. Changes in largest diameter, volume, and serum Tg were 8.36 mm (95%CI: 6.46-10.26mm), 216.09mm³, and 6.12ng/ml, respectively. Major complications occurred at 3.0%, while minor complications were 25.6%. Significant heterogeneity was found for diameter, volume, VRR, Tg, and minor complications. Subgroup analysis showed that MWA had a higher VRR (97.18%) than RFA (93.84%) (P < 0.001).
CONCLUSION: Both RFA and MWA were effective and safe for treating CLNM from PTC. However, RFA showed lower volume reduction than MWA with significant heterogeneity in VRR.
DATA AVAILABILITY STATEMENT: The original contributions revealed in the study are included in the article/Supplemental Material. Further inquiries can be made to the corresponding author.
引用
- Upadhyaya A, Upadhyaya SA, Chang L, et al. Ultrasound‑guided Percutaneous Radiofrequency and Microwave Ablation for Cervical Lymph Node Metastasis from Papillary Thyroid Carcinoma: A Systematic Review and Meta‑analysis of Clinical Efficacy and Safety. Acad Radiol. 2025. PMID: 39800601. doi:10.1016/j.acra.2024.12.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。